InvestmentMay 27, 2026, 04:13 PM
RedHill Biopharma Increases ATM Offering Amount for ADSs
AI Summary
RedHill Biopharma Ltd. announced it filed a prospectus supplement to increase the maximum aggregate offering amount of its American Depositary Shares (ADSs). These ADSs, each representing 10,000 ordinary shares, are offered under an At The Market Offering Agreement with H.C. Wainwright & Co., LLC, originally entered into on February 3, 2025.
Key Highlights
- RedHill Biopharma increased the maximum aggregate offering amount of its American Depositary Shares (ADSs).
- Each ADS represents 10,000 ordinary shares.
- The increase is under an At The Market Offering Agreement with H.C. Wainwright & Co., LLC.
- The original ATM agreement was established on February 3, 2025.
Price Impact
More from RDHL